analgesia with continuous IV-infusion of lidocain during the perioperative period in patients undergoin laparoscopic sterilization.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-001315-31-BE

Enrollment

Registered

2011-07-26

Start date

2011-09-21

Completion date

Unknown

Last updated

2021-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Trade Name: linisol 1% Product Name: linisol 1% Pharmaceutical Form: Injection INN or Proposed INN: lidocaïne hydrochloride monohydraat CAS Number: 137-58-6 Concentration unit: mg/kg/h milligram(s)/ki

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA I or II surgical sterilization > 18 years Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 80 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: allergy to lidocaine chronic use op opioids liver and renal insuffiency

Design outcomes

Primary

Measure	Time frame
Main Objective: Is the perioperative IV administration of lidocaine an effective treatment to reduce postoperative pain after surgical sterilization.;Secondary Objective: Does the IV administration of lidocaine during the perioperative period reduce: - the incidence of postoperative pain - the consumption of co-analgesics - the incidence of PONV - the length of hospital stay;Primary end point(s): Is the continuous systemic perioperative administration of lidocain effective to treat visceral pain after lararoscopic sterilisation in daycare ?;Timepoint(s) of evaluation of this end point: every 15 min. for the first 2 hours postoperatively	—

Measure

Time frame

Main Objective: Is the perioperative IV administration of lidocaine an effective treatment to reduce postoperative pain after surgical sterilization.;Secondary Objective: Does the IV administration of lidocaine during the perioperative period reduce: - the incidence of postoperative pain - the consumption of co-analgesics - the incidence of PONV - the length of hospital stay;Primary end point(s): Is the continuous systemic perioperative administration of lidocain effective to treat visceral pain after lararoscopic sterilisation in daycare ?;Timepoint(s) of evaluation of this end point: every 15 min. for the first 2 hours postoperatively

—

Secondary

Measure	Time frame
Secondary end point(s): incidence of PONV less need of analgesics to reduce postoperatvie pain;Timepoint(s) of evaluation of this end point: every 15 min. for the first 2 hours postoperatively	—

Countries

Belgium

Contacts

Public ContactAnesthesia Research

University Hospitals Leuven

christel.huygens@uzleuven.be3216344620

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026